U.S. drug agency to propose rules to rein in opioid manufacturing

Share this post

WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drugmakers in a given year, in an effort to combat the deadly opioid epidemic that has plagued the United States.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply